Bunkerhill AVC vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill AVC

by BunkerHill Health

iCAC Device

by Bunkerhill Health

AI Verdict

Tool A (Bunkerhill AVC) is a comprehensive generative AI platform offering multiple calcification detection capabilities, including aortic, mitral, and coronary artery calcification (iCAC), alongside broader clinical reasoning. Tool B (iCAC Device) is a specialized, FDA-cleared AI algorithm dedicated solely to the detection and quantification of coronary artery calcium from chest CTs. While Tool A encompasses the functionality of Tool B as one of its features, Tool B serves as a focused solution for specific coronary artery assessment.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your primary need is the early detection and precise quantification of aortic valve calcification from chest CTs. This tool is also ideal if you seek a comprehensive generative AI platform (Carebricks) that integrates deeply with your full EHR system to automate workflows and identify multiple opportunistic findings like coronary artery calcification, mitral annular calcification, and bone density.

View Bunkerhill AVC →

Choose iCAC Device if…

Choose iCAC Device if your focus is on opportunistically identifying and quantifying coronary artery calcium from routine, non-contrast, non-gated chest CT scans to aid in early cardiovascular disease detection. This solution is particularly well-suited for integration via PACS or a DICOM router, allowing for efficient screening of existing imaging data.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill AVC	iCAC Device
Pricing	Contact for pricing	Contact for pricing
Deployment	Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems.	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A, as part of the broader Carebricks generative AI platform, offers a more interactive and adaptable user experience through features like customizable AI agents and natural language processing for patient record interaction (Carebricks Chat). This allows for a wider range of clinical reasoning tasks and conversational engagement with patient data.

Clinical Value

Bunkerhill AVC

While both tools offer significant clinical value through opportunistic detection, Tool A (Bunkerhill AVC) is integrated into the Carebricks platform, which provides a broader suite of detections including aortic valve calcification, coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification, and opportunistic bone density assessment. This comprehensive approach offers more extensive clinical insights from a single chest CT scan.

Pricing & Value

Bunkerhill AVC

Both tools require contacting the vendor for pricing, offering no direct transparency. However, Tool A, being a component of the comprehensive Carebricks generative AI platform, encompasses a wider array of features, including multiple detection algorithms, NLP, and customizable agents, suggesting a higher potential overall value proposition for a health system seeking a multi-faceted AI solution.

Enterprise Readiness

Bunkerhill AVC

Tool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are critical for healthcare enterprise adoption. Its deployment integrates with 'full Electronic Health Records (EHRs) and clinical archives.' Tool B requires contacting the vendor for BAA and HIPAA details, indicating less transparency in its published specifications.

Innovation

Bunkerhill AVC

Tool A is part of the Carebricks generative AI platform, which extends beyond mere detection to encompass clinical reasoning, customizable AI agents, and natural language processing for patient record interaction (Carebricks Chat). This represents a higher degree of innovation by actively supporting decision-making and automating workflows, rather than solely providing detection results.

Support & Docs

Tie

The provided structured facts and web search results do not offer specific information regarding the support and documentation for either Tool A or Tool B. As both products are from the same company, Bunkerhill Health, it is reasonable to assume they would share similar support structures, but without explicit details, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill AVC	iCAC Device
Product Name	Bunkerhill AVC	iCAC Device
Company	BunkerHill Health	Bunkerhill Health
Tagline	Generative AI for clinical reasoning and action.	Building healthcare's system of action with AI for clinical reasoning and action.
Primary Clinical Focus	Early detection and quantification of aortic valve calcification from chest CTs.	Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans.
Additional Calcification Detections	Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification (Bunkerhill MAC), opportunistic bone density assessment (Bunkerhill BMD).	Not specified

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do Bunkerhill AVC and iCAC Device primarily detect?

Bunkerhill AVC is specifically designed for the early detection and quantification of aortic valve calcification from chest CTs. The iCAC Device, on the other hand, detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans.

How do these tools integrate with existing hospital IT infrastructure and clinical workflows?

Bunkerhill AVC integrates with full Electronic Health Records (EHRs) and clinical archives within health systems. The iCAC Device is a Software as a Medical Device (SaMD) that integrates with PACS or a DICOM router and is cloud-based via the Carebricks platform, also integrating with EHRs via Carebricks.

Do both tools provide quantitative measurements, and what are the specific output metrics?

Both tools provide quantification. Bunkerhill AVC aids in the quantification of aortic valve calcification. The iCAC Device delivers exact and four-category quantitative estimates of coronary artery calcium burden in Agatston units.

Are both tools part of a broader AI platform, or are they standalone applications?

Both tools are offered by Bunkerhill Health. Bunkerhill AVC is explicitly described as an FDA-cleared algorithm within the Carebricks generative AI platform, which offers additional features. The iCAC Device also integrates with EHRs via the Carebricks platform, suggesting it leverages the same underlying infrastructure.

What types of CT scans are compatible with each tool for analysis?

While Bunkerhill AVC aids in detection from general chest CTs, the iCAC Device specifically analyzes routine, non-contrast, non-gated chest CT scans for coronary artery calcium.